Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMultiple MyelomaMelphalanStem CellsBone Marrow TransplantationCombined Modality TherapyTreatment OutcomeGraft vs Host DiseaseRemission InductionAntineoplastic Combined Chemotherapy ProtocolsLiver TransplantationSalvage TherapyHematologic NeoplasmsHematopoietic Stem Cell MobilizationMyeloablative AgonistsRecurrenceDisease-Free SurvivalLymphoma, Non-HodgkinGraft SurvivalHematopoietic Stem CellsCyclophosphamideHodgkin DiseaseEtoposideCarmustineWhole-Body IrradiationCytarabineSurvival RateBone Marrow PurgingBusulfanRetrospective StudiesKidney TransplantationSurvival AnalysisCell TransplantationVincristineMesenchymal Stem Cell TransplantationTransplantation ChimeraAntigens, CD34Tissue DonorsThiotepaCord Blood Stem Cell TransplantationFollow-Up StudiesGranulocyte Colony-Stimulating FactorTime FactorsLeukapheresisPrognosisAmyloidosisLymphoma, Mantle-CellDexamethasoneHeart TransplantationEmbryonic Stem CellsImmunosuppressive AgentsAntibodies, Monoclonal, Murine-DerivedAntineoplastic Agents, AlkylatingThalidomideBoronic AcidsLung TransplantationHistocompatibility TestingPyrazinesDoxorubicinLeukemia, Myeloid, AcuteAdult Stem CellsPrednisoneLymphomaNeoplasm, ResidualLymphoma, FollicularMyelodysplastic SyndromesAutograftsTransplantation ImmunologyHistocompatibilityCell DifferentiationLymphoma, T-Cell, PeripheralGraft RejectionOrgan TransplantationLeukemiaAntineoplastic AgentsGraft vs Tumor EffectGraft vs Leukemia EffectPodophyllotoxinIfosfamideHematopoiesisBlood Component RemovalMesenchymal Stromal CellsPluripotent Stem CellsTransplantation, IsogeneicTransplantationIslets of Langerhans TransplantationIdarubicinInduction ChemotherapyVidarabineProspective StudiesBone Marrow CellsBone MarrowLymphoma, Large B-Cell, DiffuseFeasibility StudiesNeural Stem Cells